2059155-02-9

Basic information

• Product Name: (S)-4-(difluoromethyl)oxazolidin-2-one
• Synonyms: (S)-4-(difluoromethyl)oxazolidin-2-one;(4S)-4-(difluoromethyl)-1,3-oxazolidin-2-one
• CAS NO: 2059155-02-9
• Molecular Formula: C4H5F2NO2
• Molecular Weight: 137.0848064
• EINECS: -0
• Mol File: 2059155-02-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (S)-4-(difluoromethyl)oxazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-4-(difluoromethyl)oxazolidin-2-one(2059155-02-9)
• EPA Substance Registry System: (S)-4-(difluoromethyl)oxazolidin-2-one(2059155-02-9)

Safety Data

• Hazardous Substances Data: 2059155-02-9(Hazardous Substances Data)

Usage

General Description

(S)-4-(difluoromethyl)oxazolidin-2-one is a chemical compound that belongs to the oxazolidinone class of compounds. It is a chiral molecule, with the (S)-enantiomer being the active form. (S)-4-(difluoromethyl)oxazolidin-2-one has a difluoromethyl group attached to an oxazolidinone ring, which gives it unique properties and makes it useful in various chemical reactions and processes. It is used as a building block in the synthesis of pharmaceuticals, agrochemicals, and other fine chemicals. Its synthetic versatility and stability make it a valuable intermediate in organic synthesis and drug development. Additionally, its unique structure makes it an interesting target for research and development in the field of organic chemistry.

Upstream product

• 75-44-5 phosgene 

Relevant articles and documents

INHIBITOR CONTAINING TRICYCLIC DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

An inhibitor containing a tricyclic derivative, a preparation method therefor and a pharmaceutical composition comprising the inhibitor, as well as a use thereof as a phosphoinositide 3 kinase (PI3K) inhibitor in the treatment of cancer and diseases or conditions mediated by or dependent on PI3K imbalance.

Synthetic method of difluoromethyl substituted oxane-2-one

The invention relates to a synthetic method of difluoromethyl substituted oxane-2-one. The synthetic method uses compound III as a raw material to prepare compound I via fluorination and deprotectiontwo-step reaction; the synthetic method is simple to per

BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE

Described herein are benzoxazepin oxazolidinone compounds with phosphoinositide-3 kinase (PI3K) modulation activity or function having the Formula I structure: or stereoisomers, tautomers, or pharmaceutically acceptable salts thereof, and with the substituents and structural features described herein. Also described are pharmaceutical compositions and medicaments that include the Formula I compounds, as well as methods of using such PI3K modulators, alone and in combination with other therapeutic agents, for treating diseases or conditions that are mediated or dependent upon PI3K dysregulation.